Postmenopausal: Clinical Trials

2 trials for Postmenopausal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Postmenopausal: new trials by email Literature Review of Postmenopausal trials Research Report on Postmenopausal

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture
HLX14, Prolia® - Postmenopausal
Phase 3CompletedShanghai Henlius Biotech5142022-06-172024-09-20
Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Letrozole, Zoledronic acid - Osteoporosis, Postmenopausal
Phase 3CompletedNovartis832006-01-012011-11-16

Narrower conditions

Breast Neoplasms (1)  ·  Osteoporosis (1)

Broader conditions

Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Breast Diseases (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Denosumab (1)  ·  Letrozole (1)  ·  Zoledronic Acid (1)

Sponsors

Novartis (1)  ·  Shanghai Henlius Biotech (1)

Countries

China (1)  ·  Germany (1)

Results publications

PMID 38979716